Clovis Oncology, Inc. (CLVS) - Earnings & Price History

CLVS: Clovis Oncology, Inc. - 86.64, $3.88B, 1.37 (1.61%)

Sector: Healthcare - Industry: Biotechnology

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast cancers. It has license agreements with Advenchen Laboratories LLC, Avila Therapeutics, Inc., and Pfizer Inc.; collaboration and license agreement with Les Laboratoires Servier; a drug discovery collaboration agre

Past CLVS reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-22AMC-1.6557.7161.1962.4156.8163.831.99%-7.53%-5.69%3.28M
2016-11-03AMC-1.9527.125.926.2625.8127.31.39%3.20%4.63%1.63M
2016-08-08AMC-2.116.5515.6915.8515.2116.961.02%▲4.42%5.48%1.37M
2016-05-05AMC-2.3913.1112.6612.7412.5714.690.63%2.90%3.55%2.39M
2016-02-25AMC-2.4419.717.2916.7916.7919.95-2.89%17.33%13.94%1.69M
2015-11-05AMC-2.0799.22103.5598.2695.32103.02-5.11%0.98%-4.18%1.03M
2015-08-06AMC80.5483.1782.4778.0284.86-0.84%▲-2.34%-3.16%870.43K
2015-05-06AMC-1.8278.4979.9178.2675.8981-2.06%0.29%-1.78%799.10K
2015-02-25AMC-1.377.8976.5574.47479.8-2.81%4.69%1.75%560.80K
2014-11-06AMCClovis Oncology-1.03-1.1758.3158.5756.2354.5458.74-4.00%3.70%-0.44%890.40K
2014-08-07AMCClovis Oncology-0.93-1.0340.8836.8837.3537.0242.071.27%▲9.45%10.85%1.38M
2014-05-08AMCClovis Oncology-0.87-0.9147.8349.3249.346.4250.39-0.04%-2.98%-3.02%1.05M
2014-02-27AMCClovis Oncology-0.75-0.9279.6278.3881.179.0188.993.47%-1.82%1.58%2.51M
2013-10-31AMCClovis Oncology-0.63-0.6850.9951.1151.3849.89520.53%-0.76%-0.23%389.00K
2013-08-01BMOClovis Oncology-0.69-0.7277.3677.8879.2574.0181.811.76%▲-2.38%-0.67%384.90K
2013-05-07BMO-0.633.0138.0336.3832.220137.07-4.34%-9.26%-13.20%535.72K
2013-02-28AMC-0.7821.8118.8620.2718.7521.927.48%7.60%15.64%421.00K
2012-11-05AMC-0.6722.522.3722.462223.340.40%0.18%0.58%53.88K
2012-08-08BMOQ2 2012 Clovis Oncol-0.6115.7615.3615.514.9616.540.91%▲1.68%2.60%55.40K
2012-05-08BMOQ1 2012 Clovis Oncol-0.73-0.8617.991817.7517.7218.62-1.39%1.35%-0.06%116.50K
2012-03-08BMOQ4 2011 Clovis Oncol-0.79-1.322.42322.819.522.8-0.87%-1.75%-2.61%50.70K

Login | Register
Sunday Jul 23, 2017   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY246.88-0.22-0.09%88,660,369

Upgrades/Downgrades